CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-27 | Garren Hideki Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2023-09-13 | Garren Hideki Chief Medical Officer | Option exercise 10b5-1 | +2,000 | $24.90 | $50K | 2,000 |
| 2023-09-13 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −2,000 | $55.48 | $111K | 0 |
| 2023-09-13 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,000 | 192,000 | ||
| 2023-08-16 | Garren Hideki Chief Medical Officer | Option exercise 10b5-1 | +2,000 | $24.90 | $50K | 2,000 |
| 2023-08-16 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −878 | $58.15 | $51K | 1,122 |
| 2023-08-16 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −748 | $58.93 | $44K | 374 |
| 2023-08-16 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −374 | $59.74 | $22K | 0 |
| 2023-08-16 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,000 | 194,000 | ||
| 2023-07-12 | Garren Hideki Chief Medical Officer | Option exercise 10b5-1 | +2,000 | $24.90 | $50K | 2,000 |
| 2023-07-12 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −1,908 | $67.48 | $129K | 92 |
| 2023-07-12 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −92 | $68.20 | $6K | 0 |
| 2023-07-12 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,000 | 196,000 | ||
| 2023-06-16 | Garren Hideki Chief Medical Officer | Option exercise 10b5-1 | +7,331 | $24.90 | $183K | 7,331 |
| 2023-06-16 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −7,331 | $74.00 | $542K | 0 |
| 2023-06-16 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,331 | 198,000 | ||
| 2023-06-14 | Garren Hideki Chief Medical Officer | Option exercise 10b5-1 | +4,669 | $24.90 | $116K | 4,669 |
| 2023-06-14 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −509 | $72.45 | $37K | 4,160 |
| 2023-06-14 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −971 | $73.31 | $71K | 3,189 |
| 2023-06-14 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −2,534 | $74.59 | $189K | 655 |
Page 1 of 3 · 46 trades